Volume 55, Issue 12 pp. 2898-2904
TRANSFUSION PRACTICE

Evaluation of the in-hospital hemovigilance by introduction of the information technology–based system

Harumi Fujihara

Harumi Fujihara

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Chiaki Yamada

Chiaki Yamada

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Hiroaki Furumaki

Hiroaki Furumaki

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Seiya Nagai

Seiya Nagai

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Hiroki Shibata

Hiroki Shibata

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Keiko Ishizuka

Keiko Ishizuka

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Hiroko Watanabe

Hiroko Watanabe

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Makoto Kaneko

Makoto Kaneko

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Miwa Adachi

Miwa Adachi

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Search for more papers by this author
Akihiro Takeshita

Corresponding Author

Akihiro Takeshita

Transfusion and Cell Therapy, Hamamatsu University School of Medicine, Hamamatsu, Japan

Address reprint requests to: Akihiro Takeshita, Transfusion and Cell Therapy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan; e-mail: [email protected].Search for more papers by this author
First published: 14 July 2015
Citations: 7

Abstract

BACKGROUND

Hemovigilance is an important aspect of transfusion medicine. However, the frequency of the adverse reactions often varies using different reporters. Recently, we have employed a new information technology (IT)-based in-hospital hemovigilance system. Here, we evaluated changes in practice after implementation of an IT-based reporting system.

STUDY DESIGN AND METHODS

We compared the rate of frequency and details of blood transfusion–related adverse reactions 3 years before and after introduction of the IT-based reporting system. Contents and severity of the adverse reactions were reported in a paper-based reporting system, but input by selecting items in an IT-based reporting system. The details of adverse reactions are immediately sent to the blood transfusion unit online.

RESULTS

After we introduced the IT-based reporting system, the reported rate of transfusion-related adverse reactions increased approximately 10-fold from 0.20% to 2.18% (p < 0.001), and frequencies of urticaria, pruritus, rash, fever (p < 0.001), hypertension (p = 0.001), tachycardia (p = 0.003), and nausea and vomiting (p = 0.010) increased significantly. Although there was no error report in the paper-based reporting, incorrect reports were observed in 90 cases (0.52%) in the IT-based reporting (p < 0.001).

CONCLUSION

The advantages of IT-based reporting were: 1) a significant increase in the frequency of adverse reaction reporting and 2) a significant decrease in underreporting, although the true frequency has yet to be clarified. The disadvantage of the IT-based reporting was an increased incidence of incorrect inputs, all of which was unnoticed by the reporters. Our results showed several important points in need of monitoring after introduction of an IT-based reporting system.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.